Release Date: 15/10/12 09:22 Summary: Austin Exploration Investor Presentation Price Sensitive: No Download Document 1.71MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%